The role of phospho-proteomics in drug discovery and development
25 January 2007 | By Ze’ev Gechtman, Ph.D., formerly of Johnson & Johnson
While scientific discoveries can be turned into financial assets, the scientific process itself has proven difficult to harness to efficiently create marketed products bringing profits. This translation is especially challenging for the pharmaceutical and biotechnology industries owing to the tremendous complexity of biological systems.